- J&J Family of Companies (Raritan, NJ)
- Johnson and Johnson is recruiting for a Regulatory Program Manager, Oncology . This position can be located in Spring House, PA; Horsham, PA; Titusville, NJ; Raritan, ... we all belong. The Regulatory Program Manager (RPM) will be an asset -level operational leader, driving projects forward through the translation and distillation of… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …or working or resources to the Head of US Regulatory Affairs and/or Global Regulatory Lead for asset to reach resolution. + Participate in global product team ... 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel therapies in … more
- Merck (Rahway, NJ)
- …ability to lead a large organization. + Proven ability to build a data asset strategy & innovation agenda and lead its execution. + Strong business acumen ... responsible for creating, owning & implementing the HH data asset strategy & innovation agenda across all business units... strategy & innovation agenda across all business units ( Oncology , Vaccine, Pharma & Rare Disease), Digital, Market Access… more
- Pfizer (New York, NY)
- …research and partnerships). **ROLE RESPONSIBILITIES** + Enable Medical strategy, asset and franchise strategies through various modalities of evidence generation, ... centered research and partnerships) and other data across the asset lifecycle ( from early research and development through...needed for global and country level. + Ensure study quality , integrity, and compliance in accordance with Pfizer policies… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel therapies in ... oncology , as well as other research areas centered around...rare diseases and immune disorders. **Summary** This position will lead the valuation processes for in-licensing, out-licensing, co-development and/or… more
- Bristol Myers Squibb (Princeton, NJ)
- …of BMS. RayzeBio is developing innovative drugs against targets of solid tumors. The lead asset , RYZ101, is in Phase 3 testing for patients with ... benefit-risk profiles. The VP works cross-functionally with clinical, regulatory, medical affairs, quality , and commercial teams to support the safe use of products… more